Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual misoprostol before abdominal myomectomy for reduction of surgical blood loss
PACTR202608750764747Not yet recruiting
- Sponsor
- Nanle Musa Litkwal
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of misoprostol in Fibromyoma (LM) (2 arms), sponsored by Nanle Musa Litkwal. Primary endpoint: Mean estimated intraoperative blood loss. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
misoprostol
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on PACTR202608750764747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202608750764747.